XHKG
1418
Market cap32mUSD
Jul 07, Last price
0.15HKD
1D
-9.26%
1Q
-14.04%
Jan 2017
-76.67%
IPO
-86.00%
Name
Sinomax Group Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sinomax Group Limited functions as an investment holding company, primarily engaged in the manufacturing and distribution of health and household goods, as well as polyurethane foam. The company offers a diverse range of products such as viscoelastic pillows, mattress toppers, and mattresses, marketed under an extensive portfolio of brands including SINOMAX, Octaspring, Zeopedic, Zeosleep, PureLUX, Dream Serenity, ComforZen, Cradlez, Customizer, Design, Spa Supreme, and Tung Ah. These products are sold through various channels, including the company's own stand-alone retail outlets, concession counters located in department stores, and online platforms. Beyond its core manufacturing, Sinomax also carries out retail and wholesale operations for health and home products, alongside providing treasury management services. Its global footprint spans the People's Republic of China, Hong Kong, Macau, the United States, Canada, other North American countries, Europe, and additional international territories. Established in 2000, the company's corporate headquarters are situated in Kowloon Bay, Hong Kong. Sinomax Group Limited operates as a subsidiary of Sinomax Enterprises Limited.
IPO date
Jul 10, 2014
Employees
2,742
Domiciled in
HK
Incorporated in
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||